NPR (Rob Stein) - The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
NYTIMES (Gina Kolata) - New Gene Therapy Enables Children With a Rare Form of Deafness to Hear
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.